Better Buy: Biogen vs. Axsome Therapeutics


One biotech has been big long-time winner, the other is a promising up-and-comer with no revenue -- yet. But picking an investment is always a bet on the fu... Read more

Bron: Fool.com: The Motley Fool
Tags: Biogen
Geplaatst: 23 May 2020 - 13:36